Center for Genomic Medicine

Combining Geisel’s strengths in the biomedical application of big data and in precision medicine, investigators in the Center for Genomic Medicine are creating new insights into the genetic basis of disease and discovering ways to individually tailor diagnoses, treatments, and prevention strategies.

Goal: $10 million


Understanding Scleroderma’s ‘Social Network’ May Lead to New Treatments

Michael Whitfield, PhD, a translational genetics researcher at Dartmouth’s Geisel School of Medicine, has earned a second highly competitive award from the Dr. Ralph and Marian Falk Medical Research Trust for his pioneering work on the rare autoimmune disease systemic scleroderma.

Read More